Position in EOLS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$534,359
+$360,090 QoQ
Shares Held
76,997
+193.8% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#57
of 158 holders
Holding Since
Sep 2020
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Derivatives in EOLS
reported options exposure · as of Dec 31, 2020CallValue
$504,000
CallShares
150,000
PutValue
$173,712
PutShares
51,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ExodusPoint Capital Management, LP holds $55,176,557 across 18 Drug Manufacturers - Specialty & Generic names. EOLS ranks #15 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
150,033 | $16,644,661 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
446,179 | $10,980,465 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
744,917 | $7,449,170 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
256,843 | $4,445,952 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
32,838 | $2,718,329 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
33,017 | $2,111,437 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
49,984 | $2,050,843 | |
| 8 | ALKS |
Alkermes plc.
|
31,684 | $1,660,241 |
All Filings in EOLS
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $534,359 | 76,997 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $174,269 | 26,206 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $209,189 | 34,070 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,279,517 | 138,927 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $858,003 | 71,322 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $149,316 | 13,525 | Shares | Sole | 2025-02-12 | |
| 2023-12-31 | $531,333 | 50,459 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $1,477,867 | 203,283 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,976,606 | 470,048 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,461,177 | 327,720 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $205,275 | 25,500 | Shares | Sole | 2022-11-10 | |
| 2021-09-30 | $345,498 | 45,341 | Shares | Sole | 2021-11-15 | |
| 2020-12-31 | $504,000 | 150,000 | Call | Sole | 2021-02-16 | |
| 2020-12-31 | $668,438 | 198,940 | Shares | Sole | 2021-02-16 | |
| 2020-12-31 | $173,712 | 51,700 | Put | Sole | 2021-02-16 | |
| 2020-09-30 | $151,481 | 38,742 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||